Home > Boards > US Listed > Medical - Equipment > Guardion Health Sciences Inc. (GHSI)

All of our executive officers, directors and holders

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
JohnConnor67 Member Profile
 
Followed By 10
Posts 617
Boards Moderated 0
Alias Born 03/27/19
160x600 placeholder
Guardion Health Sciences, Inc. Reports Results for the Three and Nine Months Ended September 30, 2019 GlobeNewswire Inc. - 11/14/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/13/2019 5:27:30 PM
Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering GlobeNewswire Inc. - 10/30/2019 12:33:22 PM
Guardion Health Sciences Announces Pricing of $8.4 Million Underwritten Public Offering GlobeNewswire Inc. - 10/28/2019 9:21:39 AM
Guardion® Receives approval from USPTO for expanded claims for its Proprietary Medical Device, the MAPCAT SF GlobeNewswire Inc. - 10/23/2019 7:00:05 AM
Guardion® Announces Statistically Significant Blood Assay Study Results GlobeNewswire Inc. - 10/10/2019 10:30:00 AM
Guardion Health Sciences Acquires the NutriGuard Brand of Products GlobeNewswire Inc. - 9/23/2019 10:30:00 AM
Guardion Launches VectorVision CSV-2000 Standardized Contrast Sensitivity Test GlobeNewswire Inc. - 9/3/2019 7:00:00 AM
Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering GlobeNewswire Inc. - 8/15/2019 4:05:00 PM
Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering GlobeNewswire Inc. - 8/15/2019 8:35:14 AM
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering GlobeNewswire Inc. - 8/13/2019 9:00:00 AM
Guardion Health Sciences Reports June 30, 2019 Interim Results of Operations GlobeNewswire Inc. - 8/12/2019 8:40:00 AM
Foundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-C... GlobeNewswire Inc. - 8/6/2019 7:00:00 AM
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the Hong Kong Patents Registry GlobeNewswire Inc. - 7/17/2019 7:00:00 AM
Guardion’s Proprietary Medical Device, the MapcatSF®, Receives Patent from the European Union GlobeNewswire Inc. - 6/20/2019 7:00:00 AM
Guardion Launches Second Ocular Health Formula ‘GlaucoCetin’ GlobeNewswire Inc. - 6/4/2019 7:00:00 AM
Guardion’s Lumega-Z Formula Associated with Substantial Clinical Improvement in Patients Contrast Sensitivity Visual Functi... GlobeNewswire Inc. - 5/9/2019 10:14:43 AM
Guardion's Lumega-Z Formula Associated with Improved Vision in Patients with Severe Glaucoma GlobeNewswire Inc. - 5/7/2019 7:00:00 AM
Guardion Health Sciences, Inc. Receives Official Trademark Registrations in China GlobeNewswire Inc. - 5/1/2019 7:00:00 AM
Results of Lumega-Z Data to be Presented at ARVO GlobeNewswire Inc. - 4/17/2019 9:01:23 AM
WallachBeth Capital Announces Completion of the $5 Million IPO for Guardion Health Services PR Newswire (US) - 4/11/2019 9:18:00 AM
Guardion Health Sciences, Inc. Announces Closing of Initial Public Offering GlobeNewswire Inc. - 4/9/2019 12:20:13 PM
Guardion Health Sciences, Inc. Announces Pricing of Initial Public Offering Business Wire - 4/5/2019 12:49:00 PM
JohnConnor67   Saturday, 09/28/19 05:05:31 PM
Re: go2sleepjj post# 279
Post # of 377 
All of our executive officers, directors and holders of substantially all of our outstanding capital stock are subject to lock-up agreements that restrict their ability to transfer shares of our capital stock for 180 days from the date of the underwriting agreement that was executed in connection with our initial public offering. Such lock-up restrictions expire on or about September 26, 2019. In connection with this offering, our directors, officers and certain stockholders will be subject to additional lock-up restrictions for a period of 180 days following this offering. Future sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist